Lorenza Montagna

Author PubWeight™ 6.04^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.	Endothelium	2006	1.27
2	Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.	Neurosci Lett	2004	0.95
3	Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.	Int J Mol Med	2004	0.82
4	Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion.	Int J Mol Med	2003	0.80
5	Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride.	Hypertens Res	2005	0.80
6	Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.	BMC Cardiovasc Disord	2003	0.75
7	Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.	Clin Chim Acta	2004	0.75
8	Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.	Int J Mol Med	2004	0.75
9	Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patients.	Am J Nephrol	2004	0.75
10	Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension.	J Cardiovasc Pharmacol	2006	0.75